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Itch is a major feature of many skin diseases, which ad-
versely affects patient’s quality of life. Besides disease 
severity, psychophysiological factors have been proposed 
to influence the itch sensation. In this review the evidence 
for a biopsychosocial model of itch is described, focusing 
in particular on evidence for the effects of personality 
characteristics, external stressors, cognitive, behaviou-
ral and social factors, and the possible mediating role of 
physiological processes. Research so far indicates that 
stressors may have a role in the itch sensation of pa-
tients with skin diseases. Furthermore, cognitive factors, 
such as helplessness and worrying, and the behavioural 
response of scratching have been indicated as possible 
worsening factors. Overall, findings are in favour of a 
biopsychosocial model for the itch sensation. However, 
there is a strong need for more, methodologically sound 
research in order fully to understand the processes un-
derlying the itch sensation. Key words: itch; scratch; skin 
diseases; psychological factors; biopsychosocial model.
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Itch is a major symptom of many chronic skin conditions 
and affects a considerable number of patients with, for 
example, atopic dermatitis, contact dermatitis, urticaria 
and psoriasis (1, 2). Itch has been defined as a sensation 
that provokes the desire to scratch (3). Moreover, itch 
has been shown to lower patients’ quality of life (4–6), 
which in turn unfavourably affects the outcome of der-
matological therapies, such as photochemotherapy (7) 
and, consequently, the patients’ skin status (1, 4, 8). 
Disease severity alone usually cannot fully account for 
the intensity of itch and, although several treatments 
are available, none is generally effective (9). Due to the 
overall modest relationship between itch intensity and 
severity of the skin diseases of, for example, psoriasis 
and atopic dermatitis (4, 8, 10, 11), other factors have also 
been proposed to influence itch intensity. In addition to 
factors such as sweating, skin dryness, or physical effort, 
psychological factors have regularly been described to 
influence itch intensity (4, 8, 12). One of the most stri-
king examples of the influence of psychological factors 
on itch came from the observation that itch (and the 
scratching response) could be aggravated by showing 
individuals itch-related pictures of fleas, mites, scratch 
marks, allergic reactions, etc. (13). Furthermore, it has 
been described that psychological co-morbidity (e.g. 
clinical depression) is high among patients suffering from 
itch (14–16) and that negative emotions can increase the 
level of itch (17). 
In contrast to the traditional biomedical model (which 
focuses merely on the physical processes of a disease 
and does not take into account the role of psychosocial 
factors), the observation that disease severity alone 
usually cannot fully account for the intensity of itch, 
as well as the influence of psychological processes in 
the itch sensation, support a biopsychosocial model of 
itch in patients with chronic skin diseases. Biopsycho-
social factors can best be shown in a diathesis-stress 
model, which is based on the hypothesis that internal 
vulnerability factors (diathesis), such as personality, 
interact with external environmental factors (such as 
major life events and other stressors) to trigger a disease 
or itch (Fig. 1). In this model, cognitive, behavioural 
and social factors, such as illness cognitions, coping, 
or perceived social support can be considered as medi-
ating or moderating factors that can enhance the disease 
and symptoms of itch. It is assumed that these factors, 
at least partly, account for the effects of stressors and 
personality characteristics on disease. For example, the 
influence of a stressful event on disease activity and itch 
may be explained by how patients cope with the stress-
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ful event. Another well-known example is the effect of 
social support on the relationship between stressors and 
disease activity: stressors might unfavourably affect 
disease activity and itch only in the event of low levels 
of social support. 
Specifically for itch, scratching is an important medi-
ating factor in this model. Scratching in response to itch 
is an unconscious and autonomic response, as reflected 
by the definition of itch as an unpleasant sensation, 
which evokes the desire to scratch (17). However, due 
to a vicious itch-scratch-itch cycle, scratching may 
become a problem in its own right. These factors may, 
in turn, be affected by psychological factors of sensory 
information processing (18). For example, it has been 
reported that patients with chronic itch conditions have 
a lower threshold for sensory stimuli in general and for 
itch specifically (19–21). This might be due to changes 
in information processing, such as an attentional- or 
interpretational bias to general or itch specific stimuli, 
or catastrophizing expectations about aversive stimuli 
(19, 22).
Several physiological processes can also mediate the 
relationship between itch and psychological factors (see 
Fig. 1). It is nowadays well-known that, for example, 
specific cutaneous sensory C-nerve fibres serve as pru-
riceptors (23–25), transmitting sensory stimuli from the 
skin through the dorsal horn to the spinothalamic tract. 
Several internal mediators, e.g. histamine, serotonin, 
prostaglandins and cytokines, can bind to the nerve 
endings of these itch receptors and induce axonal firing 
(26–29). Considering the possible influence of stressors 
on itch in patients with skin diseases, external stressors 
can activate the stress response system in the brain 
(hypothalamic-pituitary-adrenal axis; HPA axis), and the 
hormones of this HPA axis in turn activate mast cells 
in the skin (30, 31). In addition, external stressors can 
induce autonomous responses, such as transpiration, 
which can also worsen itch sensations (4, 12). 
PURPOSE AND METHODS OF THIS STUDY
While research so far has focused on the individual 
components of the biopsychosocial model of itch, the 
whole model has not yet been systematically described, 
particularly with regard to the evidence for psycholo-
gical factors. Therefore, the aim of the current review 
is to summarize evidence for the biopsychosocial 
model of itch, in particular the evidence for possible 
pathways for the influence of psychological factors on 
itch. Although different forms of itch have been clas-
sified and the neurophysiology of itch greatly depends 
on the type of itch (32), in this review we will focus on 
chronic itch related to skin diseases. For this purpose, 
we will describe data about the relationship between 
itch and internal factors of relatively stable personality 
characteristics (a relatively stable pattern of individual 
thoughts, emotions and actions), external stressors, 
as well as the influence of cognitive, behavioural and 
social factors on itch in patients with skin diseases.
The electronic databases used in our search for 
relevant studies included MEDLINE (1970 to 2007), 
psychINFO (1970 to 2007), EMBASE (1980 to 2007), 
and the Cochrane Library (1993 to 2007). Based on dia-
thesis-stress models, the keywords “itch”, “itching” and 
“pruritus” were used in combination with “psychologi-
cal”, “psychiatric”, “stress”, “stressors”, “life events”, 
“hassles”, “personality”, “mood”, “affect”, “emotion”, 
“tension”, “anxiety”, “depression”, “neuroticism”, 
“scratch”, “coping”, “cognitions”, “helplessness”, 
“avoidance”, “acceptance”, “worrying”, “catastrophi-
zing”, “stigmatization”, “efficacy”, “perceived control”, 
“behaviour”, “social” and “support”. In addition, refe-
rence sections were screened manually. Only interna-
tional published studies on itch in skin diseases were 
included in this review. 
PERSONALITY CHARACTERISTICS AND ITCH
It has been suggested that certain personality traits are 
associated with the development or exacerbations of 
skin disorders (33–36). In particular, for patients with 
chronic inflammatory diseases, such as atopic derma-
titis and psoriasis, a specific personality profile (with 
a relatively stable experience of negative emotional 
states) has been suggested (33, 36–40). However, re-
search has generally failed to show that patients with 
skin diseases have such a distinct personality profile. 
Nevertheless, several emotional features (such as 
anxiety or depression) have frequently been found 
to be elevated in patients with chronic skin diseases, 
probably as a consequence of the skin disease rather 
than as a contributory cause of the skin condition (34, 
35, 39, 41–46).
There is evidence for an association between negative 
affectivity (e.g. depression and anxiety) and the outcome 
of itch and the related scratching response. For example, 
preliminary results indicate that the level of anxiety 
is correlated with the intensity of itch in patients with 
chronic skin diseases (47). Furthermore, elevated levels 
of anxiety are associated with increased conditioning 
of a scratch response in patients with atopic dermatitis 
(48). For depression, findings suggest that a depressed 
clinical state may influence the itch intensity (49–51). 
For example, the level of itch before and after standard 
dermatological treatment (of, for example, topical ste-
roids or ultraviolet-B light) in patients with psoriasis 
was significantly associated with changes in depression 
before and after treatment (50). In addition, negative 
affectivity in terms of neuroticism has also been asso-
ciated with itch intensity in patients with psoriasis as 
well as atopic dermatitis (8), while other studies have 
failed to find a relationship between itch and negative 
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affectivity (44, 46). Gupta (52) reported a correlation 
between a tendency to experience dissociative states 
(a state where the person withdraws from the body or 
reality, occurring mostly during or after psychological 
trauma) and itch in a non-clinical population.
These findings regarding personality and itch severity 
should be interpreted with caution. Although in some 
cross-sectional studies a statistically significant cor-
relation was found, the direction of causality remains 
unclear. It is reasonable that some of these previously 
described symptoms, for example anxiety, depression, 
and experiencing dissociative states, are a consequence, 
rather than a cause, of having a chronic dermatological 
disorder accompanied by chronic itch. Dissociative sta-
tes could, for example, be a functional way of coping 
with chronic itch, while it may be a way to withdraw 
from the unpleasant itch experience. In addition, there 
may be an indirect relationship between negative affect 
and itch. For example, in other chronic diseases, patients 
with more negative affectivity are known to be more 
vulnerable for dysfunctional coping styles when affect-
ed by disease (e.g. a passive-avoidant coping style), 
which in turn have been shown to be risk factors for a 
worse disease outcome (53, 54).
STRESSORS AND ITCH
Many patients (37–88%) with chronic skin diseases 
believe that there is a relationship between external 
stressors and their skin disease (55–59), and this re-
lationship has received increasing attention over the 
years (43, 58–68). Although research on this subject 
is often methodologically flawed (e.g. small sample 
size, limited number of repeated measurements), results 
suggest that stress factors are associated with disease 
severity in patients with skin diseases. For example 
one of the few prospective studies by King & Wilson 
(69), indicates that in patients with atopic dermatitis, 
self-reported stressors are predictors of disease severity 
one day later. The influence of stressors on the physical 
symptom of itch has received far less attention. While to 
our knowledge there have been no prospective studies 
on this subject, some experimental and cross-sectional 
studies indicate that stress factors can influence itch. 
For example, an early experimental study by Edwards 
et al. (70) indicated that perceived stress affected the 
capability of healthy subjects to discriminate among 
itch stimuli.
A frequently used distinction between stressors is the 
division into major life events (e.g. divorce, loss of a 
loved one) and minor life events (daily hassles of, for 
example, interpersonal conflicts or running late for an 
important meeting). Major and minor life events have 
been shown to be associated with higher levels of itch in 
the general population and in patients with skin diseases 
(50, 71, 72). Moreover, one study showed that experi-
mentally evoked stress heightened itch in patients with 
skin diseases (73). Additionally, perceived stress due to 
major or minor life events has been found to be asso-
ciated with the presence (and severity) of itch in patients 
with psoriasis in some studies (74, 75) but not in others 
(50). In skin diseases, the feeling of being stigmatized 
(e.g. the experience that others stare, feel uncomfortable 
touching patients, make annoying comments, or avoid 
contact at all) also reflects the individual’s perceived 
stress. Stigmatization has been shown to be related to 
higher levels of itch in patients with atopic dermatitis 
and psoriasis (47, 76). Furthermore, high stress reactors, 
that is patients who indicate that their disease severity 
is strongly associated with stress, reported significantly 
more itch and a stronger itch/scratch cycle than low 
stress reactors (77, 78), which suggests that stressors 
may have different effects on the symptom of itch in 
different subgroups of patients. 
Overall, studies of the relationship between stress 
factors and itch indicate that the subjective experience 
of stressors might be associated with increased itch in 
patients with skin diseases. However, further prospec-
tive and experimental research is necessary to fully 
comprehend the relationship between different types 
of stressors (life events as well as perceived stress) and 
itch in different types of skin diseases.
MEDIATING FACTORS 
As shown in Fig. 1, specific cognitive, behavioural and 
social factors are assumed to mediate a persons’ skin 
reactivity and response to itch. 
Cognitive factors
Individual differences in the long-term adjustment to 
chronic diseases may be explained by different ways 
of cognitive evaluation (illness cognitions) of the av-
ersive nature of the chronic condition and its symptom 
(45, 53). Although there are several conceptualizations 
of illness cognitions, two main constructs might be 
particularly relevant for itchy skin diseases as well as 
other chronic diseases: (i) cognitions that emphasize 
the negative meaning (e.g. helplessness or worrying); 
and (ii) cognitions that diminish the aversive meaning 
of the condition (e.g. acceptance) (53).
Helplessness. Since most chronic diseases are still incu-
rable and the course of the disease is often unpredictable, 
patients may experience helplessness because of this lack 
of control over their disease. Helplessness is reflected 
by the tendency to emphasize the negative aspects of 
the disease as being uncontrollable, unpredictable and 
unchangeable, and to generalize these feelings to all 
aspects of life (53). In line with other chronic conditions 
in which helplessness has been shown to influence phy-
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sical symptoms (53), preliminary results indicate that 
helplessness may be associated with higher levels of 
itch in skin diseases (10). Additionally, helplessness has 
been related to a lower psychological well-being (10) 
and appeared to be the strongest predictor of perceived 
stress, such as feelings of stigmatization, in patients with 
skin diseases (76). 
Worrying. Related to the concept of helplessness is the 
cognitive status of perseverative worrying. About 40% of 
patients with a chronic skin condition show general patho-
logical worrying (22, 79) and disease-specific worrying 
has been shown to be associated with more severe disease 
activity in patients with skin diseases (8, 80). Further-
more, Fortune et al. (7) reported that general worrying 
predicted the effect of UVB light therapy in patients with 
psoriasis. Patients with high levels of worrying needed 
more radiation treatments to clear their psoriasis. 
Acceptance. In contrast to helplessness and worrying, 
which focus on the negative meaning of the disease 
and seem negatively to influence the disease course, 
acceptance may have beneficial effects on skin diseases. 
Cognitions of acceptance are to acknowledge the fact 
of being chronically ill and simultaneously perceiving 
the ability to live with, and master the consequences 
of, the disease (53). Some studies have found a rela-
tionship between acceptance and physical well-being in 
patients with skin diseases (10), while others have not 
(81). Acceptance has also been shown to be correlated 
with less itch intensity (10). Since higher levels of 
psychological distress have been related to higher levels 
of helplessness and less acceptance (10), it is possible 
that these psychological cognitions mediate the distress 
caused by itch in patients with skin diseases.
Behavioural factors
For skin diseases in general, behavioural coping 
strategies are directly associated with disease-related 
outcomes in patients with chronic skin diseases (82, 
83), specifically scratching. The subjective sensation 
of itch is strongly correlated with the scratching re-
sponse (measured by behavioural indicators as well 
as questionnaires) (47, 84). The sensation of itch 
induces a universal cascade in humans and animals 
to scratch. The positive effect of scratching could be 
the removal of the causal agent, such as parasites or 
plant particles. The immediate reinforcement of scrat-
ching is the reduction of itch; however, patients with 
enduring itch due to chronic skin diseases persist in 
their scratching behaviour (even until the skin bleeds) 
and this perceived loss of control may lead to nega-
tive emotional feelings. In addition, scratching can be 
sustained by long-term reinforcement (for example, 
through attention from other people). Consequently, 
in the long-term scratching may develop into a condi-
tioned response to stressors and other stimuli beside 
itch, which may be particularly relevant in patients 
with chronic itch. As mentioned earlier, scratching 
induces several physiological responses. For example, 
it has been shown that repeated scratching decreases 
prostaglandin D2 (PGD2) levels – an itch inhibitor – in 
the skin, resulting in an increased desire to scratch and 
inducing the itch-scratch cycle (85, 86). Furthermore, 
functional positron emission tomography (fPET) and 
functional magnetic resonance imaging (fMRI) studies 
have recently showed that itch is related to brain regions 
implicated in motivational processes (e.g. orbitofrontal 
cortex, striatal region, subgenual anterieur cingulated 
cortex), which could reflect the desire to relieve the itch, 
probably through scratching (87, 88). Furthermore, 
animal studies have shown that scratching may induce 
skin conditions by influencing various immunological 
responses: less scratching behaviour has been shown 
to result in altered levels of several interleukins (IL-5, 
IL-13, IL-18, interferon-γ) (89). Although scratching 
induces relief of symptoms in the short term, scratching 
often becomes a principal problem in its own right 
in the long term, due to a vicious circle of itching, 
scratching, and scratching wounds that in turn cause 
itch. Through this vicious cycle of itch-scratch-itch, 
scratching may have an important role in the mainte-
nance and exacerbation of chronic skin disorders. In 
turn, the itch-scratch cycle has been found to correlate 
with higher levels of worrying and helplessness, less 
acceptance, and anxious-depressive mood (47, 80, 90), 
suggesting that certain psychological factors (such as 
illness cognitions, behavioural factors, and external 
stressors) may influence the itch-scratch cycle. 
In addition to scratching, other coping behaviours may 
influence the itch sensation of patients with chronic skin 
disease in the long term. In particular, enduring patterns 
of avoidant coping behaviour in response to itch attacks 
(e.g. quitting activities or retreating to a restful environ-
ment when experiencing itch) has been shown to be rela-
ted to higher levels of itch, more scratching, and higher 
levels of disease-related disability (8, 58). This is con-
sistent with findings for other chronic conditions where 
avoidance behaviour towards the disease has also been 
described negatively to influence the disease outcome. 
For example, in patients suffering from chronic pain it 
is well known that passive-avoidance behaviour negati-
vely influences long-term disease outcomes (91–93). In 
contrast to acute pain, acute itch is a trigger for increased 
activity patterns (scratching). However, chronic itching 
usually causes patients to withdraw from activities or 
to avoid daily activities, which may lead to a reduced 
quality of life in the long term. Avoidance behaviour 
has indeed been shown to be related to disease-related 
quality of life in patients with chronic skin conditions 
that are frequently accompanied by itch (82, 83).
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Social factors
Social support can be broadly defined as interactions 
or resources provided by others that may help an in-
dividual cope with stress (94). The influence of social 
support on general physical and psychological health 
outcomes has frequently been described (95–98). There 
is also relatively strong evidence that higher levels of 
social support are associated with better cardiovascular 
regulation (e.g. lower blood pressure) and immune func-
tioning. The relationship between social support and 
endocrine functioning is somewhat less clear. Although 
such relationships have repeatedly been reported, the 
underlying mechanisms are relatively unclear. For 
example, increasing solely social contact levels did 
not affect key parameters of neuroendocrine function, 
such as cortisol levels (95).
The influence of social support on itch requires more 
attention, while only a few studies address this subject. 
Preliminary results indicate that social support (percei-
ved support and size of social network) is not associated 
with itching (10, 72). However, social support may 
have a protective effect when individuals are exposed 
to possible disease-triggering events (96). Picardi et al. 
(99) investigated the role of social support in outpatients 
with recent-onset psoriasis or with exacerbation of their 
disease. Preliminary results indicate that subgroups of 
patients differ in their perceived level of social support 
(66). Social support may also have a mediating role in 
the relationship between itch and distress, since lower 
levels of social support are reported to be associated 
with higher levels of distress (10).
CONCLUSION
The aim of this review was to provide an overview 
of the evidence for a biopsychosocial model of itch 
in patients with chronic skin diseases. In particular, 
evidence for a relationship between internal factors of 
relatively stable personality traits, external stressors, 
and the influence of possible mediators (cognitive, 
behavioural and social factors) on itch was structurally 
summarized. Considering that disease severity alone 
cannot fully account for the itch sensation and the pre-
liminary empirical support for a relationship between 
the biopsychosocial pathways and itch, the theoretical 
model seems to have an additional value in gaining 
insight into the complex determinants of itch and its 
treatment in skin diseases. Overall, findings support 
the biopsychosocial model of itch. However, further 
research is needed before the underlying mechanisms 
can be fully understood. While most research into psy-
chological factors and the itch sensation is based on 
cross-sectional studies, there is a strong need for studies 
with a methodologically sound design (e.g. studies with 
an experimental or prospective design).
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